ThinkSabio

$XLO

$8.68▲ +8.6% YTD

4 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History
News
XLO ▲ +8.6% - Xilio Therapeutics, Inc.
CP $8.68▲ +8.6%Nov 3, 2026 · ThinkSabio Blog

$XLO - Xilio Therapeutics to Present at the Stifel 2026 Healthcare Conference…

News
XLO ▲ +1.5% - Xilio Therapeutics, Inc.
CP $7.68▲ +1.5%Oct 26, 2026 · ThinkSabio Blog

$XLO - Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC…

News
XLO ▲ +0.6% - Xilio Therapeutics, Inc.
CP $9.04▲ +0.6%Sep 28, 2026 · ThinkSabio Blog

$XLO - Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer…

SEC 13D/G
XLO - Xilio Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$9.10▲ 1.22%Aug 14, 2026 · ThinkSabio Blog

$XLO SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #XLO Xilio Therapeutics, Inc. : $9.10 Sector: Healthcare | YTD: 🔼…